143 related articles for article (PubMed ID: 11873516)
1. Relationships between cytoprotection and mutation prevention by WR-1065.
Grdina DJ; Murley JS; Kataoka Y; Epperly W
Mil Med; 2002 Feb; 167(2 Suppl):51-3. PubMed ID: 11873516
[TBL] [Abstract][Full Text] [Related]
2. Activation of the nuclear transcription factor kappaB (NFkappaB) and differential gene expression in U87 glioma cells after exposure to the cytoprotector amifostine.
Kataoka Y; Murley JS; Khodarev NN; Weichselbaum RR; Grdina DJ
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):180-9. PubMed ID: 12007958
[TBL] [Abstract][Full Text] [Related]
3. Delayed radioprotection by NFkappaB-mediated induction of Sod2 (MnSOD) in SA-NH tumor cells after exposure to clinically used thiol-containing drugs.
Murley JS; Kataoka Y; Cao D; Li JJ; Oberley LW; Grdina DJ
Radiat Res; 2004 Nov; 162(5):536-46. PubMed ID: 15624308
[TBL] [Abstract][Full Text] [Related]
4. Interaction of amifostine and ionizing radiation on transcriptional patterns of apoptotic genes expressed in human microvascular endothelial cells (HMEC).
Khodarev NN; Kataoka Y; Murley JS; Weichselbaum RR; Grdina DJ
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):553-63. PubMed ID: 15380592
[TBL] [Abstract][Full Text] [Related]
5. Cytoprotection by WR-1065, the active form of amifostine, is independent of p53 status in human malignant glioma cell lines.
Kataoka Y; Murley JS; Patel R; Grdina DJ
Int J Radiat Biol; 2000 May; 76(5):633-9. PubMed ID: 10866285
[TBL] [Abstract][Full Text] [Related]
6. WR-1065, an active metabolite of the cytoprotector amifostine, affects phosphorylation of topoisomerase II alpha leading to changes in enzyme activity and cell cycle progression in CHO AA8 cells.
Murley JS; Constantinou A; Kamath NS; Grdina DJ
Cell Prolif; 1997; 30(6-7):283-94. PubMed ID: 9451419
[TBL] [Abstract][Full Text] [Related]
7. Amifostine metabolite WR-1065 disrupts homologous recombination in mammalian cells.
Dziegielewski J; Goetz W; Murley JS; Grdina DJ; Morgan WF; Baulch JE
Radiat Res; 2010 Feb; 173(2):175-83. PubMed ID: 20095849
[TBL] [Abstract][Full Text] [Related]
8. The radioprotective agent, amifostine, suppresses the reactivity of intralysosomal iron.
Yu Z; Eaton JW; Persson HL
Redox Rep; 2003; 8(6):347-55. PubMed ID: 14980067
[TBL] [Abstract][Full Text] [Related]
9. WR-1065, the active metabolite of amifostine, mitigates radiation-induced delayed genomic instability.
Dziegielewski J; Baulch JE; Goetz W; Coleman MC; Spitz DR; Murley JS; Grdina DJ; Morgan WF
Free Radic Biol Med; 2008 Dec; 45(12):1674-81. PubMed ID: 18845240
[TBL] [Abstract][Full Text] [Related]
10. The effects of cycloheximide and WR-1065 on radiation-induced repair processes: a mechanism for chemoprevention.
Murley JS; Grdina DJ
Carcinogenesis; 1995 Nov; 16(11):2699-705. PubMed ID: 7586189
[TBL] [Abstract][Full Text] [Related]
11. Thiol and disulfide metabolites of the radiation protector and potential chemopreventive agent WR-2721 are linked to both its anti-cytotoxic and anti-mutagenic mechanisms of action.
Grdina DJ; Shigematsu N; Dale P; Newton GL; Aguilera JA; Fahey RC
Carcinogenesis; 1995 Apr; 16(4):767-74. PubMed ID: 7728953
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of topoisomerase II alpha activity in CHO K1 cells by 2-[(aminopropyl)amino]ethanethiol (WR-1065).
Grdina DJ; Constantinou A; Shigematsu N; Murley JS
Radiat Res; 1994 Apr; 138(1):44-52. PubMed ID: 8146299
[TBL] [Abstract][Full Text] [Related]
13. Radioprotection of cells in culture by WR-2721 and derivatives: form of the drug responsible for protection.
Smoluk GD; Fahey RC; Calabro-Jones PM; Aguilera JA; Ward JF
Cancer Res; 1988 Jul; 48(13):3641-7. PubMed ID: 2837320
[TBL] [Abstract][Full Text] [Related]
14. Protection from cellular oxidative injury and calcium intrusion by N-(2-mercaptoethyl)-1,3-propanediamine, WR 1065.
Polla BS; Donati Y; Kondo M; Tochon-Danguy HJ; Bonjour JP
Biochem Pharmacol; 1990 Oct; 40(7):1469-75. PubMed ID: 2171529
[TBL] [Abstract][Full Text] [Related]
15. Protection against radiation-induced mutagenesis at the hprt locus by spermine and N,N"-(dithiodi-2,1-ethanediyl)bis-1,3-propanediamine (WR-33278).
Shigematsu N; Schwartz JL; Grdina DJ
Mutagenesis; 1994 Jul; 9(4):355-60. PubMed ID: 7968578
[TBL] [Abstract][Full Text] [Related]
16. Delayed radioprotection by nuclear transcription factor kappaB -mediated induction of manganese superoxide dismutase in human microvascular endothelial cells after exposure to the free radical scavenger WR1065.
Murley JS; Kataoka Y; Weydert CJ; Oberley LW; Grdina DJ
Free Radic Biol Med; 2006 Mar; 40(6):1004-16. PubMed ID: 16540396
[TBL] [Abstract][Full Text] [Related]
17. Selective exclusion by the polyamine transporter as a mechanism for differential radioprotection of amifostine derivatives.
QuiƱones HI; List AF; Gerner EW
Clin Cancer Res; 2002 May; 8(5):1295-300. PubMed ID: 12006551
[TBL] [Abstract][Full Text] [Related]
18. Manganese superoxide dismutase (SOD2)-mediated delayed radioprotection induced by the free thiol form of amifostine and tumor necrosis factor alpha.
Murley JS; Kataoka Y; Baker KL; Diamond AM; Morgan WF; Grdina DJ
Radiat Res; 2007 Apr; 167(4):465-74. PubMed ID: 17388698
[TBL] [Abstract][Full Text] [Related]
19. Activation of NFkappaB and MnSOD gene expression by free radical scavengers in human microvascular endothelial cells.
Murley JS; Kataoka Y; Hallahan DE; Roberts JC; Grdina DJ
Free Radic Biol Med; 2001 Jun; 30(12):1426-39. PubMed ID: 11390188
[TBL] [Abstract][Full Text] [Related]
20. Interaction of cultured mammalian cells with WR-2721 and its thiol, WR-1065: implications for mechanisms of radioprotection.
Purdie JW; Inhaber ER; Schneider H; Labelle JL
Int J Radiat Biol Relat Stud Phys Chem Med; 1983 May; 43(5):517-27. PubMed ID: 6303973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]